Nexstim Plc launches presence in Asia with distribution agreement of its SmartFocus™ TMS system to access Hong Kong market

Helsinki, Finland: 3 October 2018 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depression Disorder (MDD), announces it has signed an agreement with Ampere Medical Limited, a specialist neuromodulation distributor based in Hong Kong.

More info on Nexstim's website.

Next > Varian Expands cancer care portfolio with Noona Healthcare acquisition

Previous > Nexstim Plc supports 10th International Symposium on Navigated Brain Stimulation in Neurosurgery and Neuromodulation